By Mariam Sunny and Sneha S K July 1 (Reuters) - Millions of Americans are expected to gain coverage for GLP-1 drugs for ...
A new pilot program for adults with Medicare Part D coverage will cut the price of Wegovy, Zepbound, and Foundayo. Find out ...
For years, GLP-1 medication has transformed conversations around weight loss but left many virtually locked out by costs. Now ...
Medicare has delayed a program for older Americans that would've required participating insurance companies to cover GLP-1 weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.
The Trump administration's promised Medicare pilot program for GLP-1 weight-lossdrugs was positioned to help cover the costs of these medications, helpingseniors avoidwasting money in retirement while ...